Hamilton Square Biotech Partners (Offshore), LP — Form D/A
Hamilton Square Biotech Partners (Offshore), LP of PRINCETON, NJ, a pooled investment fund, filed a Form D amendment with the SEC on 2025-11-13. $4.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-11-13
- Form: D/A
- Accession: 0001493152-25-022206
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $4.5M
- Investors: 2
- Date of first sale: 2025-07-14
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-547928
Issuer
- Name: Hamilton Square Biotech Partners (Offshore), LP
- CIK: 0002069766
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2025
- Address: 300 CARNEGIE CENTER, PRINCETON, NJ, 08540
- Phone: 212-679-1786
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| - Hamilton Square Biotech Partners GP, LLC | Executive Officer | Princeton, NJ |
| - Hamilton Square Partners Management, LP | Executive Officer | Princeton, NJ |
| David Tukey | Executive Officer | Princeton, NJ |
Other filings by this issuer (1)
More